Affirma Capital has agreed to invest in the Tirupati Group, a leading nutraceuticals-focussed contract research and manufacturing company in India. Affirma Capital will invest USD 50 million to support organic and inorganic growth initiatives of the company.
The group has developed capabilities to cater to the wide range of nutraceutical product portfolio basket of its customers, which includes protein supplements, ayurvedic/herbal supplements, multivitamins, minerals, fortified food and beverages, among others.
Affirma Capital is committed to backing best-in-class management teams, and continues to actively seek investment opportunities in Asia, Africa and the Middle East.
The nutraceutical industry provides an opportunity to grow multi-fold over the next few years and Tirupati Group is the market leader in the segment, on account of its deep customer relationships and strong R&D capabilities.